Wednesday's Top 10 Articles, Videos on TheStreet

NEW YORK ( TheStreet) -- In case you missed them, here are the top 10 most popular articles and videos on TheStreet today. Sign up for free email delivery of our daily Top 10.

Biotech Twitter Mailbag: Gilead, Chelsea, Keryx, Onyx, BioSante, Dendreon
Adam Feuerstein
Biotech columnist Adam Feuerstein responds to biotech stock questions posed by his Twitter followers. (Stocks include GILD, CHTP, DNDN ONXX)

More Biotech Twitter Mailbag: Orexigen, Affymax, YM Bio, Spectrum & More
Adam Feuerstein
Biotech columnist Adam Feuerstein responds to biotech stock questions posed by his Twitter followers.

Sirius Moves Closer to Being Bought (Update 1)
Chris Ciaccia
Liberty Media may double its stake to 80%, some analysts say.

10 Stocks to Own During a Dividend Bubble (Update 1)
Frank Byrt
Investors are better off balancing dividends and share-price appreciation.

3 Stocks Investors Are Selling but Should Be Buying
Andrea Tse
A 'contrarian' approach can yield big returns if investors target quality stocks.

5 Best Performing Bank Stocks in 2012
Shanthi Bharatwaj
Hopes that the European crisis might not have a significant impact on the U.S. economy and expectations that there will be greater clarity on the regulatory front have helped turn the tide for bank stocks.

Stocks Reverse Course on Bernanke Testimony
Chao Deng
Less dovish comments from Fed chief Ben Bernanke steal the market's momentum from earlier positive reads on economic growth and business activity.

Bank of America, AIG Get Upgrades
Alexandra Zendrian
These stocks receive upgrades from TheStreet Ratings on Wednesday.

Analysts' Actions: AAPL, VPHM, CVX
TheStreet Staff
Here are today's top research calls.

5 Bank Stocks That Won't Bankrupt You or America (Update 1)
Philip van Doorn
Many of this year's best bank stock performers have still not recovered from their 2011 losses. These five quality names have lagged the financial sector so far this year, but performed well last year, highlighting the group's lower relative risk.
This article was written by a staff member of TheStreet.

If you liked this article you might like

Stock Market Drop Not Seen Dampening Healthcare Deal Activity

Stock Market Drop Not Seen Dampening Healthcare Deal Activity

Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices

Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices

Centene, LabCorp Among Healthcare Stock Gainers

Centene, LabCorp Among Healthcare Stock Gainers

A Regular Winning Trade Becomes Roadkill in Market Meltdown

A Regular Winning Trade Becomes Roadkill in Market Meltdown

These 2 Biotech Stocks Still Have Upside

These 2 Biotech Stocks Still Have Upside